AT284896T
Novel antiarrhythmic peptides
Abstract
This record has no abstract on file.
Term
Term ended
Expired 22 February 2021, 5.6 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
51 members in 22 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| PA200000288 | Denmark | A | |
| PA200000738 | Denmark | A | |
| 0100127 | Denmark | W |
Members51
| Document | Office | Kind | |
|---|---|---|---|
| CA2385659A1 | Canada | A1 | |
| WO0162775A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3536201A | Australia | A | |
| WO0162775A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1226160A2 | European Patent Office (EPO) | A2 | |
| CA2439101A1 | Canada | A1 | |
| WO02077017A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2003092609A1 | United States of America | A1 | |
| NO20033641D0 | Norway | D0 | |
| JP2003528826A | Japan | A | |
| WO02077017A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20033641L | Norway | L | |
| EP1370276A2 | European Patent Office (EPO) | A2 | |
| KR20040004538A | Republic of Korea | A | |
| IL157447A0 | Israel | A0 | |
| IL157447D0 | Israel | D0 | |
| EP1226160B1 | European Patent Office (EPO) | B1 | |
| AT284896TThis record | Austria | T | |
| ATE284896T1 | Austria | T1 | |
| DE60107803D1 | Germany | D1 | |
| JP2005506295A | Japan | A | |
| PL368911A1 | Poland | A1 | |
| US2005075280A1 | United States of America | A1 | |
| DK1226160T3 | Denmark | T3 | |
| ES2228807T3 | Spain | T3 | |
| PT1226160E | Portugal | E | |
| SI1226160T1 | Slovenia | T1 | |
| US2005113293A1 | United States of America | A1 | |
| AU781674B2 | Australia | B2 | |
| EA200300912A1 | Eurasian Patent Organization (EAPO) | A1 | |
| AU2005205785A1 | Australia | A1 | |
| MXPA03007537A | Mexico | A | |
| DE60107803T2 | Germany | T2 | |
| BR0207476A | Brazil | A | |
| NZ527571A | New Zealand | A | |
| EA007792B1 | Eurasian Patent Organization (EAPO) | B1 | |
| ZA200306410B | South Africa | B | |
| CN1988914A | China | A | |
| US7250397B2 | United States of America | B2 | |
| AU2002254033B2 | Australia | B2 | |
| US7585839B2 | United States of America | B2 | |
| JP4327398B2 | Japan | B2 | |
| US7737113B2 | United States of America | B2 | |
| EP1370276B1 | European Patent Office (EPO) | B1 | |
| AT497967T | Austria | T | |
| ATE497967T1 | Austria | T1 | |
| DE60239126D1 | Germany | D1 | |
| DK1370276T3 | Denmark | T3 | |
| CA2385659C | Canada | C | |
| ES2360599T3 | Spain | T3 | |
| CA2439101C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 1907393
Titles2
- German
- NEUE ANTIARRYTHMISCHE PEPTIDE
- English
- NEW ANTIARRYTHMIC PEPTIDES
Classification
- CPC, 29
- C07K7/06
- A61K38/00
- A61P1/00
- A61P1/04
- A61P3/00
- A61P3/08
- A61P3/10
- A61P7/02
- A61P9/00
- A61P9/06
- A61P9/12
- A61P15/08
- A61P17/02
- A61P19/02
- A61P19/10
- A61P25/18
- A61P25/22
- A61P25/28
- A61P27/02
- A61P27/12
- A61P27/16
- A61P35/00
- A61P43/00
- C07K5/06139
- C07K5/06165
- C07K5/0806
- C07K5/0823
- C07K5/1008
- C07K7/64
- IPC, 34
- A61K38 00
- A61K9 20
- A61P1 00
- A61P1 04
- A61P15 08
- A61P17 02
- A61P19 02
- A61P19 10
- A61P25 18
- A61P25 22
- A61P25 28
- A61P27 02
- A61P27 12
- A61P27 16
- A61P3 00
- A61P3 08
- A61P3 10
- A61P35 00
- A61P43 00
- A61P7 02
- A61P9 00
- A61P9 06
- A61P9 12
- C07K5 06
- C07K5 062
- C07K5 078
- C07K5 08
- C07K5 083
- C07K5 097
- C07K5 10
- C07K5 103
- C07K7 00
- C07K7 06
- C07K7 64